Brokerages predict that Walgreens Boots Alliance Inc (NASDAQ:WBA) will post earnings of $1.49 per share for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have made estimates for Walgreens Boots Alliance’s earnings, with the highest EPS estimate coming in at $1.58 and the lowest estimate coming in at $1.43. Walgreens Boots Alliance posted earnings per share of $1.33 during the same quarter last year, which would indicate a positive year-over-year growth rate of 12%. The business is expected to issue its next earnings report on Thursday, July 5th.
On average, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.91 per share for the current year, with EPS estimates ranging from $5.58 to $6.00. For the next fiscal year, analysts anticipate that the firm will post earnings of $6.49 per share, with EPS estimates ranging from $6.08 to $6.74. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that follow Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. The company had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. Walgreens Boots Alliance’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period last year, the business earned $1.36 EPS.
WBA has been the subject of several research reports. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research note on Saturday, April 7th. Jefferies Group set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, April 3rd. Scotiabank decreased their price objective on shares of Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating for the company in a research note on Monday, April 2nd. Finally, Pivotal Research set a $70.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Thursday, March 29th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus price target of $83.20.
WBA stock opened at $63.82 on Friday. The company has a market capitalization of $63,506.27, a P/E ratio of 12.51, a P/E/G ratio of 1.03 and a beta of 1.16. The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 52 week low of $61.74 and a 52 week high of $87.79.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 31.37%.
In other news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 14.80% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of WBA. Parkside Investments LLC grew its holdings in shares of Walgreens Boots Alliance by 3.0% during the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock worth $1,801,000 after buying an additional 715 shares in the last quarter. BTIM Corp. boosted its position in shares of Walgreens Boots Alliance by 3.5% during the 4th quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after acquiring an additional 725 shares during the last quarter. Eads & Heald Investment Counsel boosted its position in shares of Walgreens Boots Alliance by 3.6% during the 4th quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after acquiring an additional 748 shares during the last quarter. Iberiabank Corp boosted its position in shares of Walgreens Boots Alliance by 7.0% during the 3rd quarter. Iberiabank Corp now owns 11,474 shares of the pharmacy operator’s stock valued at $886,000 after acquiring an additional 753 shares during the last quarter. Finally, IFM Investors Pty Ltd boosted its position in shares of Walgreens Boots Alliance by 3.0% during the 3rd quarter. IFM Investors Pty Ltd now owns 25,769 shares of the pharmacy operator’s stock valued at $1,990,000 after acquiring an additional 762 shares during the last quarter. 60.90% of the stock is owned by institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.